Compare SENEB & LBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SENEB | LBRX |
|---|---|---|
| Founded | 1949 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.0B |
| IPO Year | 1998 | 2025 |
| Metric | SENEB | LBRX |
|---|---|---|
| Price | $196.63 | $44.41 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $46.60 |
| AVG Volume (30 Days) | 361.0 | ★ 388.7K |
| Earning Date | 06-11-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 98.22 |
| EPS | ★ 2.85 | N/A |
| Revenue | ★ $1,314,765,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $68.99 | ★ N/A |
| Revenue Growth | ★ 4.16 | N/A |
| 52 Week Low | $103.07 | $13.40 |
| 52 Week High | $196.63 | $49.14 |
| Indicator | SENEB | LBRX |
|---|---|---|
| Relative Strength Index (RSI) | 70.98 | 66.37 |
| Support Level | $132.23 | $20.71 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 2.57 | 3.19 |
| MACD | 2.23 | 0.28 |
| Stochastic Oscillator | 100.00 | 69.16 |
Seneca Foods Corp is a provider of packaged fruits and vegetables. The facilities are comprised of plants for packaging, can manufacturing, seed production, a farming operation and a logistical support network. It manages its business almost entirely on the basis of two reportable food packaging segments: Vegetable and Fruit/Snack. Majority of revenue comes from Vegetable segment. The Other category comprises non-food operations including revenue derived from the sale of cans, ends, seed, and outside revenue from the company's aircraft operations, and certain corporate items. Its principal product offerings include canned, frozen and jarred fruits and vegetables, as well as packaged snack chips. Its brands are Aunt Nellie's, Cherry man, GREEN VALLEY, Libby's, READ, and SENECA APPLE CHIPS.
LB Pharmaceuticals Inc is a late-stage biopharmaceutical company developing novel therapies for the treatment of a wide range of neuropsychiatric disorders including schizophrenia, bipolar depression, adjunctive treatment of depressive disorder and other diseases. It is building a pipeline that leverages the broad therapeutic potential of its product candidate, LB-102, which it believes has the potential to be the first benzamide antipsychotic drug approved for neuropsychiatric disorders in the United States. LB-102 is currently in late-stage clinical development for schizophrenia and bipolar depression. The company operates as a single reportable segment in the development of novel therapies for the treatment of neuropsychiatric diseases, including schizophrenia.